Skip to main content
Part of complete coverage on

Stop taking recalled cholesterol drug, FDA advises

By Elizabeth Cohen and William Hudson, CNN
updated 9:12 AM EST, Fri November 30, 2012
Ranbaxy Pharmaceuticals issued a recall November 9 of a generic form of Lipitor that might contain specks of glass.
Ranbaxy Pharmaceuticals issued a recall November 9 of a generic form of Lipitor that might contain specks of glass.
STORY HIGHLIGHTS
  • FDA: Consumers should stop taking generic Lipitor if pills came from recalled lot
  • The drug was recalled three weeks ago
  • Some pharmacies are still telling customers it's OK to take the drug

Editor's note: The Empowered Patient is a regular feature from CNN senior medical correspondent Elizabeth Cohen that helps put you in the driver's seat when it comes to health care.

(CNN) -- The Food and Drug Administration advised concerned consumers Thursday to stop taking a popular cholesterol drug that may be contaminated with specks of glass if the pills came from one of 41 recalled lots.

The recall of generic Lipitor was initiated nearly three weeks ago by Ranbaxy Pharmaceuticals, but this is the first time the FDA -- or anyone else -- has told consumers to stop taking the drug.

The FDA also announced Thursday that Ranbaxy would stop making atorvastatin while it investigates how the glass might have gotten into the drug.

Even with these new guidelines, some pharmacies are still telling customers it's safe to take the drug.

"Patients should continue to proceed as they normally would," said Brian Henry, vice president of corporate communications at Express Scripts, on Thursday. He added that the company would not give customers refunds for the generic Lipitor, or atorvastatin.

Elizabeth Cohen
Elizabeth Cohen
Company recalls generic Lipitor

Cholesterol drug recalled over glass concerns

Henry explained that this was a "pharmacy-level recall," meaning pharmacies must stop dispensing contaminated lots of the drug, but consumers could keep taking what they already had at home -- even though the FDA has confirmed that some of the contaminated drug may have reached consumers.

Pharmacists at several CVS stores also told customers it was OK to keep taking Ranbaxy's atorvastatin but said they would replace the drug at a patient's request.

"This whole thing is confusing for consumers," said Lisa Gill, editor of prescription drugs at Consumer Reports.

She also expressed concern that it took the FDA nearly three weeks to issue guidance to consumers.

"It's not clear why it took them so long," she said. "It's surprising."

FDA spokeswoman Sarah Clark-Lynn declined to comment on the reasons behind the delay.

Recall leaves glass-specked drug in hands of patients

In its statement Thursday, the FDA said that the glass particles were "similar to the size of a grain of sand" and that "the possibility of adverse events related to the recalled product appear to be low."

Making matters potentially even more confusing, the FDA directed concerned consumers to call their pharmacies to see whether their pills had been recalled, as not all lots of the drug are effected.

However, pharmacists say they have no way of figuring out what lot number a bottle of pills came from.

"The ability to tie a specific prescription to a lot number would be very difficult," said Ronna Hauser, vice president of policy and regulatory affairs at the National Community Pharmacists Association.

Ranbaxy, India's largest pharmaceutical company and the 12th largest generics maker in the world, has had quality problems in the past.

The FDA has accused the company of "a pattern of systemic fraudulent conduct," including taking shortcuts in crucial quality tests. So widespread and grave was the misbehavior that in 2008 the FDA barred Ranbaxy from importing 30 drugs into the United States.

ADVERTISEMENT
Part of complete coverage on
Senior Medical Correspondent Elizabeth Cohen helps put you in the driver's seat when it comes to health care with her column, Empowered Patient.
updated 9:29 PM EDT, Tue October 15, 2013
For nearly two weeks, I was a failure -- a complete and utter failure. I couldn't sign up for Obamacare on Healthcare.gov.
updated 10:58 AM EDT, Thu October 3, 2013
Lots of people look at an open enrollment e-mail and essentially take a wild guess at what plan works best for them. Don't be one of them.
updated 8:18 AM EDT, Tue October 8, 2013
meat case
Despite food safety measures, the threat of foodborne illness remains in meat and produce -- and some types of illness are on the rise.
updated 2:44 PM EDT, Wed July 31, 2013
White woman has mammogram
The word "cancer" evokes scary visions of spreading tumors and death. But not all cancers are created equal.
updated 8:47 AM EDT, Sat April 6, 2013
More hospitals are hiring patient navigators to help patients through a confusing system of paperwork, specialists and lab results.
updated 4:32 PM EDT, Thu May 16, 2013
When Angelina Jolie revealed she'd had a double mastectomy, her bravery empowered other women to tell their breast cancer stories.
updated 12:49 PM EST, Wed March 6, 2013
When Crystal Kelley agreed to carry someone else's baby, she didn't, in her words, "dot every 'i' and cross every 't.'"
updated 5:25 PM EST, Mon November 5, 2012
When you're a patient, you trust you're in good hands, but even the best doctor or nurse can make a mistake on you or someone you love.
updated 10:45 AM EST, Thu November 8, 2012
Egg freezing technology has improved so much that egg banks have started websites where patients can order and ship frozen eggs.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT